Loading...

TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Company Mergers 8-K Filing

TV P

TV

TEVA PHARMACEUTICAL INDUSTRIES LTD

(TEVA)

2026 8-K

Financial Results & Acquisi...

Financial Results Announced

Credit Agreement Update

Financial Results Update

Financial Statements

Debt Restructuring

Equity Offerings

Financial Statements

Financial Results

Board Appointment

Q3 Financial Results

Financial Results Announcement

Agreement with Israeli Tax ...

Annual Meeting Voting Results

Departure and Appointment o...

Financial Results Announcement

Change in Reporting Segments

Financial Results Announcement

Financial Results Announcement

Collaboration with Sanofi

Departure and Appointment

Entry into a Material Defin...

Appointment of Director

Financial Results Announcement

Annual Meeting Voting Results

Settlement Agreement for Op...

Resignation of Director

Financial Results

External Links:

On April 29, 2026, Teva Pharmaceutical Industries Ltd. reported its financial results for Q1 2026 and announced its agreement to acquire Emalex Biosciences. This filing is a significant event as it highlights both financial performance and a strategic acquisition.

AI Assistant

TEVA PHARMACEUTICAL INDUSTRIES LTD

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.